GlycoRegimmune's Unattributed Round

GlycoRegimmune raised a round of funding on April 17, 2015.

GlycoRegimmune is a development stage biotech company fundamentally changing the way inflammatory disease is treated.…

Articles about GlycoRegimmune's Unattributed Round: